@rndmguy197 @lm_vix @Elizz224 @jakescottMD Looking back over the letter, it is extending EUA for applications which were not covered in the BLA. That is not the BLA; it is an extension of EUA for not-yet-fully-approved uses of the Pfizer vaccine. Again, that insight is right on page 2 (footnotes make it clearer).